Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02830893 · ClinicalTrials.gov registry record · NA
Efficacy Study of the LARA Wheelchair System for Subacute Stroke Patients
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02830893 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 23 participants.
The verdict
NCT02830893, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study will test the effectiveness of a new lever drive wheelchair, LARA - Lever Actuated Resonance Assistance. LARA facilitates patients in performing a high amount of practice using their moderate to severely impaired upper extremity after stroke. Investigators will recruit 44 subjects with subacute strokes to participate in the study through the acute rehabilitation unit of the UC Irvine Douglas Hospital. Study participants will be randomized into 2 groups: LARA therapy group or standard therapy group. The LARA therapy group will use LARA to propel themselves to therapy appointments in the unit and to play video games with the affected upper extremity for 30 mins / day. The standard therapy group will use a standard wheelchair to propel themselves using their unaffected upper and lower extremities. They will be asked to perform a matched duration of standard arm exercises for 30 mins/ day. This program of standard arm exercises was developed by an OT at the Rehabilitation Institute of Chicago which consists of graded-difficulty table-supported exercises. This study will have 3 assessment visits: baseline, 3 weeks after therapy or upon discharge from the acute rehabilitation unit if sooner, and a 3-month follow up.
Interventions
- BEHAVIORAL Standard
- DEVICE LARA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2019-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02830893
The ClinicalTrials.gov registry entry for NCT02830893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard is the first listed.
NCT02830893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02830893 about?
NCT02830893 is a clinical study titled "Efficacy Study of the LARA Wheelchair System for Subacute Stroke Patients". This study will test the effectiveness of a new lever drive wheelchair, LARA - Lever Actuated Resonance Assistance. LARA facilitates patients in performing a high amount of practice using their moderate to severely impaired upper extremity after stroke. Investigators will recruit 44 subjects with s...
What is the current status of trial NCT02830893?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2017-02-15. Estimated completion is 2019-01-10.
What interventions are being tested in trial NCT02830893?
The interventions under investigation include: Standard (BEHAVIORAL), LARA (DEVICE).
Who is sponsoring clinical trial NCT02830893?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.